Inhibikase Therapeutics I... (IKT)
2.30
-0.04 (-1.71%)
At close: Feb 28, 2025, 3:59 PM
2.29
-0.43%
After-hours: Feb 28, 2025, 04:19 PM EST
Inhibikase Therapeutics Revenue
Inhibikase Therapeutics reported an annual revenue of $260.5K, reflecting a 111.03% growth. For the quarter ending September 30, 2024, Inhibikase Therapeutics generated $0 in revenue.
Revenue (ttm)
$260.5K
Revenue Growth
111.03%
Price / Sales Ratio
26
Revenue / Employee
$32.56K
Employees
8
Market Cap
159.53M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| 2023-12-31 | 260.5K | +111.03% |
| 2022-12-31 | 123.44K | -96.02% |
| 2021-12-31 | 3.1M | +343.92% |
| 2020-12-31 | 698.47K | n/a |